Brind.

Michel Detheux's company partnered with GSK, and Detheux joined Vor's board of directors in July 2025.

1 report, 1 independent Updated Jul 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

GSK VOR

Keep exploring

The entities involved

GSK
British multinational pharmaceutical and biotechnology company
- Clement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Mon 15:26
- GSK acquired Sierra Oncology.Mon 14:28
VOR
company in the Czech Republic

Nothing else this week.

Related events

GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16

Coverage

Newest first; wire copies grouped

Jul 29Insider MonkeyVor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board We recently published These 10 Stocks are Winning Big. Vor Biopharma Inc. (NASDAQ:VOR) is one of the best-performing stocks on Monday. Vor